Expression of PD-L1 by tumor cells and effect of anti-PD-1 immune therapy has been clearly demonstrated in Hodgkin’s lymphoma, a tumor which is constantly associated with both NF-κB and STAT3 activation. The gene discussed is CD274; the disease is neoplasm.